ARA330521 is an experimental peptide developed by Araim Pharmaceuticals designed to provide tissue protective and anti inflammatory effects without stimulating red blood cell production. It is part of the company’s non hematopoietic erythropoietin mimetic program, which aims to preserve the cytoprotective and immune modulating properties of erythropoietin while avoiding its erythropoietic activity. Preclinical research suggests ARA330521 may help reduce inflammation, protect cells from oxidative and ischemic damage, and support tissue repair, while potentially minimizing risks such as elevated hemoglobin levels or thrombosis associated with conventional erythropoietin therapies.
These are the replacement Rear Suspension Arms for the Arrma 4S BLX Kraton and Outcast.